Home Nav
Nextech Invest Logo
Nextech Invest

Nextech Invest believes that the scientific quality, world class management and investor syndicate are imperative for a winning company. We select investee companies accordingly.

Unmet expertise in scientific and clinical development, and outstanding leadership, combined with a novel and high quality scientific approach is the foundation for the success of a company.

We invest with strong investor syndicates to support the company through different developmental stages with the aim to reach a timely exit, preferably via trade sale - the route independent from financial market conditions.

Emerging cancer treatments

Emerging cancer treatments are continuously improving efficacy and side effects for the benefit of patients. Antibody therapies and targeted inhibitors selectively kill cancer cells while sparing healthy cells. Immunotherapies can train the patients' own failing immune system to attack/conquer cancer cells.

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close